SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010432
Filing Date
2020-05-12
Accepted
2020-05-12 16:16:09
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20200331_10q.htm 10-Q 456519
2 EXHIBIT 31.1 ex_184637.htm EX-31.1 14021
3 EXHIBIT 31.2 ex_184638.htm EX-31.2 13809
4 EXHIBIT 32.1 ex_184639.htm EX-32.1 4920
5 EXHIBIT 32.2 ex_184640.htm EX-32.2 5075
  Complete submission text file 0001437749-20-010432.txt   2363240

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snbp-20200331.xml EX-101.INS 375155
7 XBRL TAXONOMY EXTENSION SCHEMA snbp-20200331.xsd EX-101.SCH 30181
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20200331_cal.xml EX-101.CAL 25538
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20200331_def.xml EX-101.DEF 181806
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20200331_lab.xml EX-101.LAB 168748
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20200331_pre.xml EX-101.PRE 200465
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 20869308
SIC: 2834 Pharmaceutical Preparations